OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome
Source Xu et al., 2019 · Rutgers University · 10.1016/j.stem.2019.04.014
Abstract
This protocol generates ventral forebrain organoids and neuronal chimeric mouse brains from Down syndrome and control human iPSCs to study OLIG2-driven overproduction of GABAergic interneurons. The 3D organoid model demonstrates increased OLIG2 expression in DS cells and excess CR+ and SST+ GABAergic neuron production compared to controls, which can be reversed by OLIG2 knockdown.
Protocol overview
20 steps across 7 phases
- 1 Initiate neural differentiation in embryoid bodies
- 2 Culture on Matrigel-coated dishes
- 3 Isolate and expand rosettes
- 4 Dissociate pNPCs and initiate organoid formation
- 5 Pattern organoids to ventral forebrain fate
- 6 Transition to orbital shaker culture
- 7 Initiate neuronal differentiation
- 8 Culture organoids to week 8
- 9 Prepare cells for transplantation
- 10 Anesthetize neonatal mice
- 11 Perform stereotaxic injection
- 12 Wean and house mice
- 13 Perform behavioral testing at 6 months
- 14 Prepare brain tissue for analysis
- 15 Perform RNA extraction and qPCR
- 16 Perform RNA sequencing
- 17 Perform chromatin immunoprecipitation (ChIP)
- 18 Perform immunostaining of organoid sections
- 19 Generate OLIG2 knockdown hiPSC lines
- 20 Verify OLIG2 knockdown
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Xu et al., 2019. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol